clozapine-n-oxide and Weight-Gain

clozapine-n-oxide has been researched along with Weight-Gain* in 2 studies

Other Studies

2 other study(ies) available for clozapine-n-oxide and Weight-Gain

ArticleYear
Arcuate nucleus and lateral hypothalamic CART neurons in the mouse brain exert opposing effects on energy expenditure.
    eLife, 2018, 08-21, Volume: 7

    Cocaine- and amphetamine-regulated transcript (CART) is widely expressed in the hypothalamus and an important regulator of energy homeostasis; however, the specific contributions of different CART neuronal populations to this process are not known. Here, we show that depolarization of mouse arcuate nucleus (Arc) CART neurons via DREADD technology decreases energy expenditure and physical activity, while it exerts the opposite effects in CART neurons in the lateral hypothalamus (LHA). Importantly, when stimulating these neuronal populations in the absence of CART, the effects were attenuated. In contrast, while activation of CART neurons in the LHA stimulated feeding in the presence of CART, endogenous CART inhibited food intake in response to Arc CART neuron activation. Taken together, these results demonstrate anorexigenic but anabolic effects of CART upon Arc neuron activation, and orexigenic but catabolic effects upon LHA-neuron activation, highlighting the complex and nuclei-specific functions of CART in controlling feeding and energy homeostasis.

    Topics: Adipose Tissue, Brown; Animals; Arcuate Nucleus of Hypothalamus; Behavior, Animal; Body Temperature; Clozapine; Dependovirus; Eating; Energy Metabolism; Hypothalamic Area, Lateral; Injections; Integrases; Mice, Inbred C57BL; Mice, Transgenic; Nerve Tissue Proteins; Neurons; Neurotransmitter Agents; Physical Conditioning, Animal; Reproducibility of Results; Weight Gain

2018
Rapid, reversible activation of AgRP neurons drives feeding behavior in mice.
    The Journal of clinical investigation, 2011, Volume: 121, Issue:4

    Several different neuronal populations are involved in regulating energy homeostasis. Among these, agouti-related protein (AgRP) neurons are thought to promote feeding and weight gain; however, the evidence supporting this view is incomplete. Using designer receptors exclusively activated by designer drugs (DREADD) technology to provide specific and reversible regulation of neuronal activity in mice, we have demonstrated that acute activation of AgRP neurons rapidly and dramatically induces feeding, reduces energy expenditure, and ultimately increases fat stores. All these effects returned to baseline after stimulation was withdrawn. In contrast, inhibiting AgRP neuronal activity in hungry mice reduced food intake. Together, these findings demonstrate that AgRP neuron activity is both necessary and sufficient for feeding. Of interest, activating AgRP neurons potently increased motivation for feeding and also drove intense food-seeking behavior, demonstrating that AgRP neurons engage brain sites controlling multiple levels of feeding behavior. Due to its ease of use and suitability for both acute and chronic regulation, DREADD technology is ideally suited for investigating the neural circuits hypothesized to regulate energy balance.

    Topics: Agouti-Related Protein; Animals; Arcuate Nucleus of Hypothalamus; Brain; Clozapine; Eating; Energy Metabolism; Feeding Behavior; Female; Male; Mice; Mice, Transgenic; Neurons; Weight Gain

2011